We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
-4.57%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$9.86B
AUM Growth
-$803M
Cap. Flow
+$275M
Cap. Flow %
2.79%
Top 10 Hldgs %
30.57%
Holding
177
New
20
Increased
25
Reduced
25
Closed
19

Top Buys

1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$123M
2
NPCE icon
Neuropace
NPCE
+$93.1M
3
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$77.8M
4
JANX icon
Janux Therapeutics
JANX
+$77.2M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$74.2M

Top Sells

1
HAE icon
Haemonetics
HAE
+$94.6M
2
ABCL icon
AbCellera Biologics
ABCL
+$54.5M
3
ADVM
Adverum Biotechnologies
ADVM
+$54.2M
4
MOH icon
Molina Healthcare
MOH
+$38M
5
PAND
Pandion Therapeutics Inc. Common Stock
PAND
+$31.7M

Sector Composition

1 Healthcare 95.36%
2 Technology 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
51
Thermo Fisher Scientific
TMO
$200B
$55.6M 0.56%
110,300
– –
OMIC
52
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$54.9M 0.56%
+66,617
New +$51.6M
MREO
53
Mereo BioPharma
MREO
$51.3M
– –
0
– –
BNR
54
Burning Rock Biotech
BNR
$101M
$54.7M 0.55%
185,620
-4,146
-2% -$1.23M
SEM
55
DELISTED
Select Medical
SEM
$53.7M 0.54%
+2,359,162
New +$49M
CMMB
56
Chemomab Therapeutics
CMMB
$11.5M
$49M 0.5%
644,544
– –
TELA icon
57
TELA Bio
TELA
$37M
$48.8M 0.49%
3,027,542
– –
APLT
58
DELISTED
Applied Therapeutics
APLT
$46.9M 0.48%
2,257,387
– –
TERN
59
DELISTED
Terns Pharmaceuticals
TERN
$46.5M 0.47%
3,791,204
– –
VTGN icon
60
VistaGen Therapeutics
VTGN
$10.1M
$45.6M 0.46%
482,262
+195,462
+68% +$14.5M
DBTX
61
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$42.5M 0.43%
4,945,192
– –
NVAX icon
62
Novavax
NVAX
$1.38B
$42.5M 0.43%
200,295
+44,462
+29% +$8.15M
TCDA
63
DELISTED
Tricida, Inc. Common Stock
TCDA
$41.5M 0.42%
9,614,280
– –
ORIC icon
64
Oric Pharmaceuticals
ORIC
$1.11B
$41.4M 0.42%
2,337,574
– –
IMA
65
ImageneBio Inc
IMA
$67.8M
$41.2M 0.42%
244,495
– –
SIBN icon
66
SI-BONE Inc
SIBN
$769M
$41.1M 0.42%
1,305,300
– –
MRSN
67
DELISTED
Mersana Therapeutics
MRSN
$38M 0.39%
112,010
+36,310
+48% +$13.7M
IRON icon
68
Disc Medicine
IRON
$2.88B
$37.7M 0.38%
194,207
– –
LOGC
69
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$37.6M 0.38%
8,466,783
– –
VRNA
70
DELISTED
Verona Pharma
VRNA
$37.2M 0.38%
5,694,841
– –
HARP
71
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$36.2M 0.37%
261,131
+32,561
+14% +$6.21M
NSTG
72
DELISTED
NanoString Technologies, Inc.
NSTG
$36M 0.37%
556,000
-66,900
-11% -$4.25M
LENZ
73
LENZ Therapeutics
LENZ
$153M
$34M 0.34%
+158,044
New +$27.5M
TRIL
74
DELISTED
Trillium Therapeutics Inc.
TRIL
$32.2M 0.33%
3,322,300
+157,100
+5% +$1.48M
GHRS icon
75
GH Research
GHRS
$1.82B
$31M 0.31%
+1,428,666
New +$29.2M
1 2
3
4 5

Similar funds

CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $4.61B AUM 25.58% 1-Year Est. Return